Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
Public ClinicalTrials.gov record NCT04099251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy With Nivolumab Versus Placebo After Complete Resection of Stage IIB/C Melanoma
Study identification
- NCT ID
- NCT04099251
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 790 participants
Conditions and interventions
Conditions
Interventions
- Nivolumab Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2019
- Primary completion
- Jun 27, 2022
- Completion
- Nov 29, 2026
- Last update posted
- Jun 22, 2026
2019 – 2026
United States locations
- U.S. sites
- 32
- U.S. states
- 21
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0088 | Birmingham | Alabama | 35294-3300 | — |
| Local Institution - 0126 | Tucson | Arizona | 85724-5024 | — |
| Local Institution - 0087 | Springdale | Arkansas | 72762 | — |
| Local Institution - 0080 | Los Angeles | California | 90025 | — |
| Local Institution - 0077 | San Francisco | California | 94115 | — |
| Local Institution - 0119 | San Francisco | California | 94115 | — |
| Local Institution - 0122 | San Jose | California | 95119 | — |
| Local Institution - 0121 | Vallejo | California | 94589-2441 | — |
| Local Institution - 0109 | Vallejo | California | 94589 | — |
| Local Institution - 0120 | Vallejo | California | 94589 | — |
| Local Institution - 0091 | Aurora | Colorado | 80045 | — |
| Local Institution - 0089 | Washington D.C. | District of Columbia | 20057 | — |
| Local Institution - 0141 | Atlanta | Georgia | 30342 | — |
| Local Institution - 0132 | Chicago | Illinois | 60611 | — |
| Local Institution - 0135 | Baltimore | Maryland | 21237 | — |
| Local Institution - 0078 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0127 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0143 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0151 | Minneapolis | Minnesota | 55407 | — |
| Local Institution - 0081 | Robbinsdale | Minnesota | 55407 | — |
| Local Institution - 0079 | Omaha | Nebraska | 68130 | — |
| Local Institution - 0093 | Hackensack | New Jersey | 07601 | — |
| Local Institution - 0094 | New York | New York | 10016 | — |
| Local Institution - 0086 | Charlotte | North Carolina | 28204 | — |
| Local Institution - 0099 | Cleveland | Ohio | 44195 | — |
| Local Institution - 0076 | Portland | Oregon | 97213 | — |
| Local Institution - 0092 | Allentown | Pennsylvania | 18103 | — |
| Local Institution - 0031 | Pittsburgh | Pennsylvania | 15232 | — |
| Local Institution - 0148 | Germantown | Tennessee | 38138 | — |
| Local Institution - 0144 | Austin | Texas | 78731 | — |
| Local Institution - 0085 | Dallas | Texas | 75246 | — |
| Local Institution - 0090 | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04099251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04099251 live on ClinicalTrials.gov.